Page 44 - IMO-2-3

Innovative Medicines & Omics Tyrosine kinases: Structure, mechanism, and therapeutics

Oncogene. 2013;32(50):5582-5592. of the catalytic subunit of cyclic adenosine monophosphate-
dependent protein kinase. Science. 1991;253(5018):407-414.
doi: 10.1038/onc.2013.277
85. Golubovskaya VM. Targeting FAK in human cancer: From doi: 10.1126/science.1862342
finding to first clinical trials. Front Biosci (Landmark Ed). 97. Roskoski R Jr. Src protein-tyrosine kinase structure
2014;19(4):687-706. and regulation. Biochem Biophys Res Commun. 2004;
324(4):1155-1164.
doi: 10.2741/4236
86. Yoon H, Dehart JP, Murphy JM, Lim ST. Understanding the doi: 10.1016/j.bbrc.2004.09.171
roles of FAK in cancer: Inhibitors, genetic models, and new 98. Okada M, Nakagawa H. A protein tyrosine kinase
insights. J Histochem Cytochem. 2015;63(2):114-128. involved in regulation of pp60c-src function. J Biol Chem.
doi: 10.1369/0022155414561498 1989;264(35):20886-20893.
87. Ganguly SS, Fiore LS, Sims JT, et al. c-Abl and Arg 99. Zheng XM, Resnick RJ, Shalloway D. A phosphotyrosine
are activated in human primary melanomas, promote displacement mechanism for activation of Src by PTPalpha.
melanoma cell invasion via distinct pathways, and drive EMBO J. 2000;19(5):964-978.
metastatic progression. Oncogene. 2012;31(14):1804-1816. doi: 10.1093/emboj/19.5.964
doi: 10.1038/onc.2011.361 100. EswarKumar N, Yang CH, Tewary S, et al. An integrative
88. Greuber EK, Smith-Pearson P, Wang J, Pendergast AM. Role approach unveils a distal encounter site for rPTPε
of ABL family kinases in cancer: From leukaemia to solid and phospho-Src complex formation. Structure.
tumours. Nat Rev Cancer. 2013;13(8):559-571. 2023;31(12):1567-1577.e5.
doi: 10.1038/nrc3563 doi: 10.1016/j.str.2023.09.004
89. Engen JR, Wales TE, Hochrein JM, et al. Structure and 101. Gazdar AF. Activating and resistance mutations of
dynamic regulation of Src-family kinases. Cell Mol Life Sci. EGFR in non-small-cell lung cancer: Role in clinical
2008;65(19):3058-3073. response to EGFR tyrosine kinase inhibitors. Oncogene.
2009;28 Suppl 1(Suppl 1):S24-S31.
doi: 10.1007/s00018-008-8122-2
doi: 10.1038/onc.2009.198
90. Hubbard SR. Structural analysis of receptor tyrosine kinases.
Prog Biophys Mol Biol. 1999;71(3):343-358. 102. Bazley LA, Gullick WJ. The epidermal growth factor receptor
family. Endocr Relat Cancer. 2005;12 Suppl 1:S17-S27.
doi: 10.1016/S0079-6107(98)00047-9
doi: 10.1677/erc.1.01032
91. Lawrence MC, Ward CW. Structural features of the receptor
tyrosine kinase ectodomains. In: Wheeler DL, Yarden Y, 103. Kumar A, Petri ET, Halmos B, Boggon TJ. Structure and
editors. Receptor Tyrosine Kinases: Structure, Functions and clinical relevance of the epidermal growth factor receptor in
Role in Human Disease. Berlin: Springer New York; 2015. human cancer. J Clin Oncol. 2008;26(10):1742-1751.
p. 163-193. doi: 10.1200/jco.2007.12.1178
92. Süveges D, Jura N. Structural features of the kinase domain. 104. Schmitz KR, Bagchi A, Roovers RC, van Bergen en
In: Wheeler DL, Yarden Y, editors. Receptor Tyrosine Kinases: Henegouwen PM, Ferguson KM. Structural evaluation
Structure, Functions and Role in Human Disease. Berlin: of EGFR inhibition mechanisms for nanobodies/VHH
Springer New York; 2015. p. 195-223. domains. Structure. 2013;21(7):1214-1224.
93. Eshaq AM, Flanagan TW, Hassan SY, et al. Non-receptor doi: 10.1016/j.str.2013.05.008
tyrosine kinases: Their structure and mechanistic role
in tumor progression and resistance. Cancers (Basel). 105. Ferguson KM. Structure-based view of epidermal growth
2024;16(15):2754. factor receptor regulation. Annu Rev Biophys. 2008;37:353-373.
doi: 10.3390/cancers16152754 doi: 10.1146/annurev.biophys.37.032807.125829
94. Brown MT, Cooper JA. Regulation, substrates and functions 106. Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the
of src. Biochim Biophys Acta. 1996;1287(2-3):121-149. epidermal growth factor receptor kinase domain alone and
in complex with a 4-anilinoquinazoline inhibitor. J Biol
doi: 10.1016/0304-419x(96)00003-0
Chem. 2002;277(48):46265-46272.
95. Abram CL, Courtneidge SA. Src family tyrosine kinases and doi: 10.1074/jbc.M207135200
growth factor signaling. Exp Cell Res. 2000;254(1):1-13.
107. Schultz DF, Billadeau DD, Jois SD. EGFR trafficking: Effect
doi: 10.1006/excr.1999.4732
of dimerization, dynamics, and mutation. Review. Front
96. Knighton DR, Zheng JH, Ten Eyck LF, et al. Crystal structure Oncol. 2023;13:1258371.

Volume 2 Issue 3 (2025) 38 doi: 10.36922/IMO025200022